- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Page 50
Daily Deal Round Up: July 23, 2021
Branding services provider Tailor Brands raised $50m in a GoDaddy-led series C round while Orix is set to exit hiring software developer PandoLogic in a $150m acquisition.
Jul 23, 2021VTex veers to $361m IPO
The SoftBank-backed e-commerce services platform developer listed on the New York Stock Exchange, pricing the shares above their range.
Jul 23, 2021Visa cuts to $963m Currencycloud acquisition
BNP Paribas, SBI Group, Siam Commercial Bank, GV and Rakuten are set to exit the cross-border payment platform in a $963m acquisition by Visa.
Jul 23, 2021Caribou Biosciences careers on to public markets
The Corteva, Novartis, AbbVie and Heritage Medical Systems-backed cancer therapy developer priced a $304m initial public offering at the top of its range.
Jul 23, 2021Couchbase sits pretty in $200m IPO
Docomo Capital-backed database software provider Couchbase floated above its range in an offering following some $250m in venture funding.
Jul 23, 2021Dook Media reads A-okay for IPO
The Legend Capital-backed paper and digital book publisher has listed on SZSE’s ChiNext market having raised $9.6m.
Jul 23, 2021Daily Deal Round Up: July 22, 2021
Several corporates backed a $68m series D round for microbiome drug developer Vedanta Biosciences while grooming brand owner Pangaea raised the same amount from investors including Unilever.
Jul 22, 2021CloudWalk gets the nod for IPO
The Bohai, Haier and PCI-Suntek-backed facial recognition technology developer has been approved to float on Shanghai’s Star Market in a $574m offering.
Jul 22, 2021IsoPlexis applies itself to IPO filing
Danaher is in line to exit proteomics platform developer IsoPlexis in a Nasdaq Global Market offering with a $100m placeholder target.
Jul 22, 2021PacBio to pick up Omniome in $800m deal
Nan Fung and Lam Research are set to exit the DNA sequencing technology developer in an $800m acquisition by market peer Pacific Biosciences.
Jul 22, 2021
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.